Cargando…

The bacterial effector protein YopM reduces rheumatoid arthritis (RA) outcome by inhibiting inflammation and bone destruction

Detalles Bibliográficos
Autores principales:	Bertrand, J, Rueter, C, Cromme, C, Scharnert, J, Schmidt, A, Pap, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332443/ http://dx.doi.org/10.1186/ar3609

Ejemplares similares

The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation
por: Ratner, Dmitry, et al.
Publicado: (2016)

Caspase-3 Mediates the Pathogenic Effect of Yersinia pestis YopM in Liver of C57BL/6 Mice and Contributes to YopM's Function in Spleen
por: Ye, Zhan, et al.
Publicado: (2014)

Toward a molecular pathogenic pathway for Yersinia pestis YopM
por: Uittenbogaard, Annette M., et al.
Publicado: (2012)

Crystal structure of an engineered YopM-InlB hybrid protein
por: Breitsprecher, Dennis, et al.
Publicado: (2014)

IQGAP1 Is Important for Activation of Caspase-1 in Macrophages and Is Targeted by Yersinia pestis Type III Effector YopM
por: Chung, Lawton K., et al.
Publicado: (2014)

Yersinia Virulence Factor YopM Induces Sustained RSK Activation by Interfering with Dephosphorylation
por: Hentschke, Moritz, et al.
Publicado: (2010)

The Yersinia Type III secretion effector YopM Is an E3 ubiquitin ligase that induced necrotic cell death by targeting NLRP3
por: Wei, Congwen, et al.
Publicado: (2016)

Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells
por: Berneking, Laura, et al.
Publicado: (2016)

The Yersinia YopE and YopH type III effector proteins enhance bacterial proliferation following contact with eukaryotic cells
por: Bartra, Sara, et al.
Publicado: (2001)

Gene therapy in rheumatoid arthritis: how to target joint destruction?
por: Pap, Thomas, et al.
Publicado: (1999)

Genome-wide gene expression in experimental arthritis: defining new targets of chronic/destructive rheumatoid arthritis (RA)
por: Takahashi, N, et al.
Publicado: (2002)

Mechanism of host substrate acetylation by a YopJ family effector
por: Zhang, Zhi-Min, et al.
Publicado: (2017)

Delivery of antisense constructs and ribozymes to inhibit cartilage destruction in the SCID mouse model of RA
por: Pap, T, et al.
Publicado: (2001)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Effects of TIMP-1 and TIMP-3 gene transfer on invasiveness, proliferation and apoptosis of rheumatoid arthritis (RA) synovial fibroblasts (RA-SF)
por: Pap, T, et al.
Publicado: (2002)

The GAP Activity of Type III Effector YopE Triggers Killing of Yersinia in Macrophages
por: Wang, Xiaoying, et al.
Publicado: (2014)

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis
por: Wäldele, Stefan, et al.
Publicado: (2015)

Lysozyme and its biological value in rheumatoid arthritis (RA)
por: Smirnow, J, et al.
Publicado: (2001)

IL2RA is associated with persistence of rheumatoid arthritis
por: van Steenbergen, H.W., et al.
Publicado: (2015)

Intestinal anaerobic bacteria in early rheumatoid arthritis (RA)
por: Toivanen, P, et al.
Publicado: (2002)

Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates
por: Molina, Emily, et al.
Publicado: (2015)

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice
por: Stratis, Athanasios, et al.
Publicado: (2012)

MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
por: Meyer, Lars-Henrik, et al.
Publicado: (2005)

Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
por: Pap, Thomas, et al.
Publicado: (2000)

Overview: Destruction of the Extracellular Matrix in Rheumatoid Arthritis
por: Krane, Stephen
Publicado: (2000)

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2014)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

A hydrophobic anchor mechanism defines a deacetylase family that suppresses host response against YopJ effectors
por: Bürger, Marco, et al.
Publicado: (2017)

Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
por: Sabokbar, Afsie, et al.
Publicado: (2017)

Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles
por: Coleman, Matthew A., et al.
Publicado: (2016)

Androgens in rheumatoid arthritis: when are they effectors?
por: Cutolo, Maurizio
Publicado: (2009)

Investigation of serum cartilage oligomer protein (COMP) levels in rheumatoid arthritis (RA)
por: Brozik, M, et al.
Publicado: (2002)

Premature Ejaculatory Dysfunction in Rheumatoid Arthritis (PED-RA Study)
por: Wagan, Abrar Ahmed, et al.
Publicado: (2022)

Roles of MicroRNAs in Bone Destruction of Rheumatoid Arthritis
por: Zhao, Hanxiao, et al.
Publicado: (2020)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Mechanisms of Yersinia YopO kinase substrate specificity
por: Lee, Wei Lin, et al.
Publicado: (2017)

Inflammasome Activation in Response to the Yersinia Type III Secretion System Requires Hyperinjection of Translocon Proteins YopB and YopD
por: Zwack, Erin E., et al.
Publicado: (2015)

YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis
por: Amer, Ayad A. A., et al.
Publicado: (2016)

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme
por: Yamanaka, Hisashi, et al.
Publicado: (2017)

A survey of a footwear service for people with Rheumatoid Arthritis (RA)
por: Field, Robert
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4sbobf7c8nebmokvo288c50c5c